Autoantibodies against GAD65 kilodalton subunit have been found in several non-neurologic and neurologic diseases such as diabetes mellitus type 1, thyroid disease, SPS, limbic encephalitis, and cerebellar ataxias [2,7-9]. This evidence concerns the gene GAD2 and aceruloplasminemia.